healthcare
healthcare Articles
ProQR Therapeutics shares made a massive gain early on Wednesday after the firm announced positive interim results from its Phase 1/2 clinical trial in patients with Leber's congenital amaurosis 10.
Published:
Last Updated:
Clinical-stage biopharmaceutical company Principia Biopharma has amended its filing with the SEC for its initial public offering.
Published:
Last Updated:
BioCryst Pharmaceuticals shares fell on Tuesday after the company announced initial results from its hereditary angioedema trial.
Published:
Last Updated:
Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The California state Assembly on Wednesday approved a bill that limits the amount dialysis centers can charge patients. The legislation, if passed by the Senate and signed by the governor, may...
Published:
Last Updated:
InsysTherapeutics shares made a handy gain early on Thursday after the company announced an update from the FDA.
Published:
Last Updated:
Results of a new study of firearm-related deaths were published Tuesday in the Journal of the American Medical Association. Just six countries accounted for half the total in 2016 with Brazil and the...
Published:
Last Updated:
Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.
Published:
Last Updated:
Affimed shares more than doubled early on Tuesday after it was announced that the firm entered into a strategic collaboration agreement with Genentech.
Published:
Last Updated:
Commercial-stage medical device company Ra Medical Systems has amended its filing with the SEC for its initial public offering.
Published:
Last Updated:
Tilray shares hit an all-time high on Monday after the company announced a new partnership with the Nova Scotia Liquor to receive an initial purchase order for adult-use cannabis.
Published:
Last Updated:
Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Kala Pharmaceuticals shares dipped on Thursday after the U.S. Food and Drug Administration (FDA) announced that it had approved INVELTYS (loteprednol etabonate ophthalmic suspension) 1% for the...
Published:
Last Updated: